TY  - JOUR
A1  - Kaltdorf, Martin
A1  - Breitenbach, Tim
A1  - Karl, Stefan
A1  - Fuchs, Maximilian
A1  - Kessie, David Komla
A1  - Psota, Eric
A1  - Prelog, Martina
A1  - Sarukhanyan, Edita
A1  - Ebert, Regina
A1  - Jakob, Franz
A1  - Dandekar, Gudrun
A1  - Naseem, Muhammad
A1  - Liang, Chunguang
A1  - Dandekar, Thomas
T1  - Software JimenaE allows efficient dynamic simulations of Boolean networks, centrality and system state analysis
JF  - Scientific Reports
N2  - The signal modelling framework JimenaE simulates dynamically Boolean networks. In contrast to SQUAD, there is systematic and not just heuristic calculation of all system states. These specific features are not present in CellNetAnalyzer and BoolNet. JimenaE is an expert extension of Jimena, with new optimized code, network conversion into different formats, rapid convergence both for system state calculation as well as for all three network centralities. It allows higher accuracy in determining network states and allows to dissect networks and identification of network control type and amount for each protein with high accuracy. Biological examples demonstrate this: (i) High plasticity of mesenchymal stromal cells for differentiation into chondrocytes, osteoblasts and adipocytes and differentiation-specific network control focusses on wnt-, TGF-beta and PPAR-gamma signaling. JimenaE allows to study individual proteins, removal or adding interactions (or autocrine loops) and accurately quantifies effects as well as number of system states. (ii) Dynamical modelling of cell–cell interactions of plant Arapidopsis thaliana against Pseudomonas syringae DC3000: We analyze for the first time the pathogen perspective and its interaction with the host. We next provide a detailed analysis on how plant hormonal regulation stimulates specific proteins and who and which protein has which type and amount of network control including a detailed heatmap of the A.thaliana response distinguishing between two states of the immune response. (iii) In an immune response network of dendritic cells confronted with Aspergillus fumigatus, JimenaE calculates now accurately the specific values for centralities and protein-specific network control including chemokine and pattern recognition receptors.
KW  - cellular signalling networks
KW  - computer modelling
Y1  - 2023
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-313303
VL  - 13
ER  - 
TY  - JOUR
A1  - Liang, Chunguang
A1  - Bencurova, Elena
A1  - Psota, Eric
A1  - Neurgaonkar, Priya
A1  - Prelog, Martina
A1  - Scheller, Carsten
A1  - Dandekar, Thomas
T1  - Population-predicted MHC class II epitope presentation of SARS-CoV-2 structural proteins correlates to the case fatality rates of COVID-19 in different countries
JF  - International Journal of Molecular Sciences
N2  - We observed substantial differences in predicted Major Histocompatibility Complex II (MHCII) epitope presentation of SARS-CoV-2 proteins for different populations but only minor differences in predicted MHCI epitope presentation. A comparison of this predicted epitope MHC-coverage revealed for the early phase of infection spread (till day 15 after reaching 128 observed infection cases) highly significant negative correlations with the case fatality rate. Specifically, this was observed in different populations for MHC class II presentation of the viral spike protein (p-value: 0.0733 for linear regression), the envelope protein (p-value: 0.023), and the membrane protein (p-value: 0.00053), indicating that the high case fatality rates of COVID-19 observed in some countries seem to be related with poor MHC class II presentation and hence weak adaptive immune response against these viral envelope proteins. Our results highlight the general importance of the SARS-CoV-2 structural proteins in immunological control in early infection spread looking at a global census in various countries and taking case fatality rate into account. Other factors such as health system and control measures become more important after the early spread. Our study should encourage further studies on MHCII alleles as potential risk factors in COVID-19 including assessment of local populations and specific allele distributions.
KW  - COVID-19
KW  - population coverage
KW  - MHC II
KW  - MHC I
KW  - B-cell
KW  - T-cell
KW  - epitope mapping
KW  - lethality rate
KW  - infection spread
KW  - SARS-CoV-2
Y1  - 2021
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-258936
SN  - 1422-0067
VL  - 22
IS  - 5
ER  -